|
ZNF621 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17540000002625E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.80690000000694E-05 |
| Normal-vs-Stage2 |
9.232200E-02 |
| Normal-vs-Stage3 |
9.421800E-01 |
| Normal-vs-Stage4 |
8.739400E-01 |
| Stage1-vs-Stage2 |
4.815000E-01 |
| Stage1-vs-Stage3 |
2.948500E-02 |
| Stage1-vs-Stage4 |
1.111380E-01 |
| Stage2-vs-Stage3 |
1.139240E-01 |
| Stage2-vs-Stage4 |
1.123760E-01 |
| Stage3-vs-Stage4 |
8.621400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.69749999999947E-05 |
| Normal-vs-AfricanAmerican |
7.216000E-03 |
| Normal-vs-Asian |
8.228200E-01 |
| Caucasian-vs-AfricanAmerican |
6.730200E-01 |
| Caucasian-vs-Asian |
4.599200E-01 |
| AfricanAmerican-vs-Asian |
4.923000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.91899999999868E-05 |
| Normal-vs-Female |
4.379800E-04 |
| Male-vs-Female |
1.972230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.759500E-02 |
| Normal-vs-Extreme_Weight |
2.056000E-02 |
| Normal-vs-Obese |
4.276900E-03 |
| Normal-vs-Extreme_Obese |
1.345610E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.318000E-01 |
| Normal_Weight-vs-Obese |
3.260200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.745200E-01 |
| Extreme_Weight-vs-Obese |
1.883160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.382400E-01 |
| Obese-vs-Extreme_Obese |
9.519000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.278100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.24270000004356E-06 |
| Normal-vs-Age(61-80Yrs) |
1.315060E-03 |
| Normal-vs-Age(81-100Yrs) |
9.939600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.336000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.874200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.257600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.856600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.298400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.315200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.70569999738512E-09 |
| Normal-VS-Type2 PRCC |
3.999400E-01 |
| Normal-VS-KIRP CIMP |
6.415800E-01 |
| Normal-VS-Unclassified PRCC |
4.723500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.53680002057399E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.042590E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.707800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.162800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.762470E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.888450E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.866220E-01 |
| Normal-vs-N1 |
8.072400E-01 |
| Normal-vs-N2 |
3.948200E-02 |
| N0-vs-N1 |
2.008800E-01 |
| N0-vs-N2 |
2.179500E-03 |
| N1-vs-N2 |
2.008800E-01 |
|
|
